STRINGENT SCREENING STRATEGY LEADS TO SIGNIFICANT REDUCTION OF TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING ANTI-TNF THERAPY: A REAL-WORLD COHORT ANALYSIS FROM A TUBERCULOSIS ENDEMIC REGION

被引：0
|
作者：
Kumar, Peeyush
Vuyyuru, Sudheer K.
Kumar, Bhaskar
Sahu, Pabitra
Goyal, Sandeep
Madhu, Deepak
Jain, Saransh
Ranjan, Mukesh K.
Mundhra, Sandeep
Golla, Rithvik
Singh, Mukesh K.
Virmani, Shubi
Sharma, Raju
Makharia, Govind K.
Kedia, Saurabh
Ahuja, Vineet
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1067
引用
收藏
页码：S870 / S870
页数：1
相关论文
共 50 条
  • [11] Clinical features of tuberculosis infection in inflammatory bowel disease patients on anti-TNF therapy
    Estevez-Gil, M.
    De Castro, M. L.
    Hernandez, V.
    Pineda, J. R.
    Martinez-Cadilla, J.
    Pereira, S.
    Rodriguez-Prada, J-I
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S309 - S309
  • [12] Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening
    Debeuckelaere, Celine
    De Munter, Paul
    Van Bleyenbergh, Pascal
    De Weyer, Walter
    Van Assche, Gert
    Rutgeerts, Paul
    Vermeire, Severine
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (06): : 550 - 557
  • [13] Safety of anti-TNF introduction following tuberculosis treatment in Inflammatory Bowel Disease patients in an endemic area
    Azevedo, M. F. C. D.
    Justus, F. F.
    Lima, C. C. G.
    Garcia, K. S.
    Barros, L. L.
    Oba, J.
    Carlos, A. D. S.
    Milani, L. R.
    Sipahi, A. M.
    Damiao, A. O. M. C.
    Queiroz, N. S. F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S445 - S445
  • [14] Different presentation of tuberculosis associated with anti-TNF therapy among patients with Inflammatory Bowel Disease in endemic area: observation from China
    Ye, L.
    Wu, L.
    Tang, J.
    Mao, R.
    Cao, Q.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I464 - I464
  • [15] Different presentation of tuberculosis associated with anti-TNF therapy among patients with Inflammatory Bowel Disease in endemic area: observation from China
    Ye, L.
    Wu, L.
    Tang, J.
    Mao, R.
    Cao, Q.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I464 - I464
  • [16] Tuberculosis infection in inflammatory bowel disease patients after anti-TNF therapy in a high tuberculosis prevalence rate area
    De Castro, M. L.
    Hernandez, V.
    Pineda, J. R.
    Pereira, S.
    Martinez-Cadilla, J.
    Sanroman, L.
    Rodriguez-Prada, I.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S191 - S192
  • [17] A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNF Therapy for Inflammatory Bowel Disease
    Jang, Eun Jin
    Ha, Jung Eun
    Im, Seul Gi
    Kim, Myeong Gyu
    Sohn, Hyun Soon
    CLINICAL DRUG INVESTIGATION, 2019, 39 (07) : 625 - 630
  • [18] A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease
    Eun Jin Jang
    Jung Eun Ha
    Seul Gi Im
    Myeong Gyu Kim
    Hyun Soon Sohn
    Clinical Drug Investigation, 2019, 39 : 625 - 630
  • [19] Screening for tuberculosis in Inflammatory Bowel Disease patients treated with immunosupressant medications versus Anti-TNF medications
    Bornstein, L.
    Sidhu, H.
    Borum, M.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S41 - S41
  • [20] Physicians inconsistently perform tuberculosis screening in Inflammatory Bowel Disease patients managed with anti-TNF agents
    Kenney, Adam
    Jakhete, Neha
    Gordon, Joseph A.
    Watts, Kate
    Borum, Marie L.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S45 - S45
12345